Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 Apr 20;15(4):e0231421. doi: 10.1371/journal.pone.0231421

Swelling characteristics and biocompatibility of ionic liquid based hydrogels for biomedical applications

Johanna Claus 1,2, Andreas Brietzke 3, Celina Lehnert 1,2, Stefan Oschatz 3, Niels Grabow 2,3, Udo Kragl 1,2,*
Editor: Feng Zhao4
PMCID: PMC7170238  PMID: 32310981

Abstract

Polymers are commonly used in medical device manufacturing, e.g. for drug delivery systems, bone substitutes and stent coatings. Especially hydrogels exhibit very promising properties in this field. Hence, the development of new hydrogel systems for customized application is of great interest, especially regarding the swelling behavior and mechanical properties as well as the biocompatibility. The aim of this work was the preparation and investigation of various polyelectrolyte and poly-ionic liquid based hydrogels accessible by radical polymerization. The obtained polymers were covalently crosslinked with N,-methylenebisacrylamide (MBAA) or different lengths of poly(ethyleneglycol)diacrylate (PEGDA). The effect of different crosslinker-to-monomer ratios has been examined. In addition to the compression curves and the maximum degree of swelling, the biocompatibility with L929 mouse fibroblasts of these materials was determined in direct cell seeding experiments and the outcome for the different hydrogels was compared.

Introduction

Since the 1960s, hydrogels are widely used in the medical and pharmaceutical industry as implants,[1] drug delivery-systems,[2,3] matrices for enzyme immobilization,[4] contact lens material,[5] tissue engineering and stent coatings.[6] Exploiting chemical and/or physical crosslinking enhances the mechanical properties such as stiffness, surface hardness, resilience to temperature and solvent attacks as well as swelling behavior.[7] Furthermore, hydrogels exhibit a variety of highly interesting properties such as outstanding biocompatibility, non-toxicity, biodegradability and a possible self-healing nature.[8,9] Those characteristics are frequently and broadly demanded and make such hydrogel based materials attractive for medical applications. Hence, a thorough control of the mechanical and swelling properties is crucial for tailor made products.[10]

A noticeable example was reported by Verma et. al describing the use of self-expanding, hydrophilic osmotic hydrogels for eyeball reconstruction in anophthalmia, to prevent the deformation of the skull.[11] The dry gels absorb the surrounding tissue fluid, swell up to ten times of their initial volume and build up the necessary counterpressure within the skull.[12] Compared to conventional, often rigid eye prostheses, frequently made of special glass, the shape flexibility of hydrogels, which grow simultaneously with the patient, offers an enormous advantage.[13] Moreover, a novel therapy of the degeneration of the intervertebral disc is of great interest in the medical community. Inserting a hydrogel stick into the interior of the intervertebral disc might be a much gentler method for the patient in comparison to a complete replacement of the disc, with a prosthesis consisting of different alloys, polyethylene, polyurethane and/or ceramics.[14] After complete swelling, the gel can relieve the weakened disc and support it in its functionality. Hence, being a minimal invasive procedure, the surgery is improved and can be performed in twilight sleep.[15]

However, recent research is still focusing on adjusting durability, degradability as well as mechanical properties and swelling behavior for more and more special fields of application. A current approach for hydrogel synthesis is the use of monomers derived from ionic liquids, which are polymerized to yield polyelectrolytes. These compounds are of special interest since the inherent properties can be easily fine-tuned by carefully selecting and combining different ionic functionalization to specifically exploit the advantages of both, ionic liquids and solid polymer structures, enhancing mechanical stability, improved processability and durability.[6] In addition to this, ionic liquids have an excellent ionic conductivity up to their decomposition temperature. The resulting hydrogels based on ionic liquids can be applicable as a conductor material.[16] Ohno et al., for instance, described thermoresponsive polyelectrolyte and poly(ionic liquid) hydrogels with reversible water-uptake and release and aqueous salt solutions.[17,18] Annabi et al. investigated hydrogels based on poly(ethylene glycol) with adjustable degree of swelling and mechanical properties, showing potential for self-inflating tissue expanders.[19] Additionally, Bandomir et al. described the mechanical and thermal characteristics of imidazolium-based polymerized ionic liquids mainly focusing on the mechanical characterization.[10]

These examples illustrate only a fraction of the manifold adjustable properties of hydrogels and therefore possible applications and potential impact in the medical field. For the development of further innovations, as well as for the comprehension of transport and release mechanisms, a deeper understanding of the mechanical strength, physicochemical properties and biocompatibility is indispensable. Especially biocompatibility is a decisive obstacle in the approval process for medical and pharmaceutical applications and therefore serves as an early exclusion criterion for novel chemical compounds within the development process. In fact, there are only a few studies on natural compound-based hydrogels that focus not exclusively on chemical and physical but also on biological evaluation.[20] Furthermore, those studies were limited to cell viability studies on hydrogel eluates, which, however, represent only a part of the in vitro test methods crucial within the early approval process. In complement to eluate tests, approaches in which cell models were exposed in direct contact to the materials are also mandatory. Thus, another prior aim of this work was to develop and to establish a direct contact test procedure, including preparation of hydrogel specimen as well as quantitative analysis of the metabolic activity and microscopic imaging using L929 mouse fibroblasts as a cell model.

In summary, the tested hydrogels exhibit excellent biocompatibility in direct contact tests paired with outstanding mechanical performance. This is of significant relevance regarding biomedical applications. Our work did not only prove that no toxic residuals may leach out and disturb cell growth, but moreover that the evaluated hydrogel materials represent a suitable matrix for cell growth. Thus, polyionic liquid based hydrogel coatings support the formation of a full-covering cell layer, and may therefore have a mitigating influence on the foreign body reaction to implants. In combination with the mechanical properties and the ability to swell in water contact, hydrogel coatings are of special interest for implant applications such as stent or pacemaker coatings.

Experimental section

Materials and methods

Chemicals

N,Nʼ-methylenebis(acrylamide) (MBAA, 99%; Sigma-Aldrich), poly(ethyleneglycol)diacrylate (PEGDA, Mn = 250, 575, 700; Sigma-Aldrich); ethyleneglycoldimethacrylate (≥97%; TCI), N,N,,-tetramethylethylendiamine (TMEDA, ≥99.5%; Sigma-Aldrich), ammoniumpersulfate (APS, 98%; Roth), 3-sulfopropylmethacrylate potassium (98%; Sigma-Aldrich), 3-sulfopropylacrylate potassium (Sigma-Aldrich), 2-acrylamido-2-methyl-1-propanesulfonicacid (99%; Sigma-Aldrich), (vinylbenzyl)trimethylammonium chloride (99%; ACROS Organics), [2-(acryloyloxy)ethyl]trimethylammonium chloride (80 wt.% in H2O; Aldrich), [2-(methacryloyloxy)ethyl]trimethylammonium chloride (75 wt.% in H2O; Aldrich), 2-hydroxyethylmethacrylate (97%; Alfa Aesar), [2-(methacryloyloxy)ethyl]dimethyl-(3-sulfopropyl)ammoniumhydroxide (95%; Sigma-Aldrich), 2-methacryloyloxyethylphosphorylcholine (97%; Sigma-Aldrich), 1-vinylimidazole (≥99%; Alfa Aesar), bromoethane(≥99%; Sigma-Aldrich), amino-2-propanol(93%; TCI), methacrylicanhydride (94%; Alfa Aesar) were all used as received without further treatment. 1-Vinyl-3-ethyl-imidazoliumbromide (VEtImBr) and 2-Hydroxypropyl methacrylamide (HPMAA) were prepared according to published procedures.[21,22]

General procedure for the syntheses of hydrogels containing polyelectrolyte monomers

All polyelectrolyte hydrogels were synthesized by radical polymerization. The monomer and the related amount of the crosslinker (2 mol% in respect to the monomer) were dissolved in deionized water, adjusting the total monomer concentration to 2 mol/L. Subsequently, APS solution was added (0.1 mol% in degassed water in respect to monomer amount). The reaction solution was degassed for 15 min and the required amount of the TMEDA solution was added (1.9 mol% of total monomer amount in degassed water). After a short mixing, the reaction mixture was poured into cylindrical molds (10 mm height × 6 mm diameter), closed airtight and let rest for 24 h at 22 ± 2°C. Elemental analyses and ATR measurements were carried out for all hydrogels and are listed in the Supporting Information.

Mechanical characterization

The hydrogels were deformed by compression at 22 ± 2°C with a single-column zwicki-line testing machine Z 2.5 [Zwick/Roell] equipped with a 50 N load cell and jaw inserts. All measurements were performed in triplicates and analyzed with testXpert standard. The synthesized cylindrical hydrogels were subsequently compressed with a speed of 2 mm/min.

Evaluation of swelling behavior

Solvent uptake kinetics of freshly synthesized hydrogels were studied gravimetrically in water at 37°C as a function of time in a strainer. The weights of the swollen gels were determined at different intervals, after dripping through the strainer and dabbing the samples off, until the equilibrium swelling was attained. The degree of swelling was calculated according to the following equation:

qt=WtW0-1

W0 is the initial weight and Wt the final weight of the gel after the time t. Each degree of swelling is reported as an average of three separate measurements and within standard deviation.[23]

Biocompatibility

Preparation of hydrogel specimen

For biocompatibility testing, 1 mL of the monomer-crosslinker solution was polymerized between two 50 mm diameter cover slips to obtain specimen with the maximum possible surface. Furthermore, the capillary force between cover slips ensured a minimal layer thickness, which is a basic requirement for cell culture and microscopy. Hydrogels were swollen in deionized water (10 mL) and washed with a minimum of three water exchanges within 72 h. Due to the correlation of swelling behavior and ion concentration, the hydrogels were put into a phenol red free cell culture medium over night to avoid volume changes during the cell cultivation. For screening test n = 4 specimen of 6 mm diameter were punched out and put on a 96-well microtiter plate.

Cell culture and cell viability assay

L929 mouse fibroblasts (CCL-1, ATCC) were cultured in Dulbeccoʼs Modified Eagle Medium (DMEM, PAN BIOTECH, Aidenbach, Germany) with 4.5 mg Glucose, 10% fetal calf serum (FCS), 1% Penicillin/Streptomycin and 3.7 g/L NaHCO3. 1x104 L929 mouse fibroblasts were seeded directly on the hydrogel specimen with 200 μL culture medium per well and incubated under cell culture conditions (37°C, 5% CO2) for 46 hours (fibroblast cell density 62500 cellsxcm2). To assess relative cell viability, a resazurin based CellQuanti-Blue Cell Viability Assay Kit (BioAssay systems, Hayward, CA, USA) was implemented. 10% CellQuanti-Blue supplement was added to the wells followed by an incubation of another 2 hours under same conditions. The metabolic turnover from resazurin to the fluorescent resorufin (absorption 544 nm, emission 590 nm) was detected with the Fluostar optima (BMG LABTECH, Ortenberg, Germany). Replicates (n ≥ 3) were tested for normal distribution and subjected to a Nalimovs’ test for outliers. Means and standard errors (SEM) were calculated in Sigma Plot.

Cytochemical analysis and microscopic imaging

For the evaluation of cell morphology and cell adhesion light microscopy was carried out with Nikon Eclipse TS100 inverted microscope and Nikon digital sight DS-Fi1 digital camera. Cells were stained with Calcein AM (Thermo Fisher Waltham, MA, USA) to prove the viability of the living cells. Calcein AM is activated via hydrolyses by intracellular esterase and binding to calcium, which in turn leads to the emission of fluorescence (515 nm). The general procedure for the treatment of the cells includes one washing step with PBS and 30 min staining with a 1:200 Calcein AM staining solution in PBS. Imaging was realized with an Olympus IX81 confocal laser scanning microscope (CLSM, for Calcein staining 488 nm excitation and 505–605 nm fluorescence imaging filters).

Results and discussion

Synthesis

All hydrogels used in this study were synthesized by free radical polymerization starting from different monomers (Fig 1), using MBAA and PEGDA with various chain lengths as crosslinker and APS/TMEDA as initiator system.

Fig 1. Overview of the monomers used within this study (3-sulfopropylmethacrylate potassium (MAE-SO3); 3-sulfopropylacrylate potassium (AE-SO3); 1-vinyl-3-ethylimidazoliumbromide (VEtImBr); (vinylbenzyl)trimethylammonium chloride (TMA-VB); [2-(acryloyloxy)ethyl]trimethylammonium chloride (AE-TMA); [2-(methacryloyloxy)ethyl]trimethylammonium chloride (MAE-TMA); [2-(methacryloyloxy)ethyl]dimethyl-(3-sulfopropyl)ammoniumhydroxide (MAEDMA-SO3); 2-methacryloyloxyethylphosphorylcholine (MPC); 2-acrylamido-2-methyl-1-propanesulfonicacid (AAMPSO3H);2-hydroxypropyl methacrylamide (HPMAA); hydroxyethylmethacrylate (HEMA)).

Fig 1

A general reaction scheme can be found in Fig 2. APS and TMEDA form two main types of primary initiating radicals through an initiation mechanism via a charge transfer complex and a cyclic transient state. The initiation of the vinyl based monomers and crosslinkers and the subsequent hydrogel-forming chain reaction is caused by the prior formed free radicals (Fig 2).[24,25]

Fig 2. Hydrogel synthesis via radical polymerization of a monomer and MBAA as an example for the crosslinker.

Fig 2

Mechanical characterization

Stress-compression curves are widely used in technical studies to specify mechanical behavior like stiffness or stability for a broad range of polymers and are essential for the use in biomedical applications (e.g. as artificial tissue).[10] For comparison, all hydrogels were synthesized with a monomer concentration of 2 mol/L and a crosslinker ratio of 2 mol%. All hydrogels can be treated as a Gaussian network following Hookeʼs law over a specific range of deformation. In the linear phase of the compression curves, they deform resiliently and can return to their original length once the stress has been relieved. The slope of this linear segment correlates with the modulus of elasticity. Above a certain point, the sample do not return to its original state and is referred to as break-fracture point.[10,26] Interestingly, poly(TMA-VB) could be highly compressed up to 88.8 ± 1.2% and stress values of 3.2 kPa were recorded and gained their original shape, when the stress is relieved (Fig 3). Below this fracture point poly(TMA-VB) gained their original shape under 3 min.

Fig 3. Compression and release of poly (TMA-VB) [22 ± 2 °C; M: 2 mol/L; MBAA 2 mol%].

Fig 3

The stress-compression curves for poly(VEtImBr), poly(MAE-SO3), poly(MAE-TMA) and poly(AAMPSO3H) hydrogels showed similar slopes (Fig 4A). Other strong deformable hydrogels were the zwitterionic poly(MPC) and poly(MAEDMA-SO3) with a maximum of compression of 82.4 ± 0.8% and 83.3 ± 1.4% (Table 1, S14 and S15 Figs). In addition, the high stress resistance of poly(AE-TMA) to 5.9 kPa till break and a compression of 77.6 ± 0.9% are also taken into account. The additional methyl group of the polymerizable acryl group, being the only structural difference between poly(AE-SO3) and poly(MAE-SO3), strongly influences the materials properties. The hydrogel poly(MAE-SO3) showed only a deformability of 59.7 ± 0.6% and a stress resistance of 1.0 kPa, whereas poly(AE-SO3) showed a maximum of compression at 72.8 ± 1.7 (Fig 4A). This trend is not seen for the maximum of compression but even more pronounced for the stress-at-break for the hydrogels poly(AE-TMA) and poly(MAE-TMA). The greater steric hindrance of the hydrogels owning the additional methyl group explains this tendency. In the literature, the compression modulus of poly(HEMA) range from less than 1 kPa to greater than 500 kPa [27,28] whereas we observed a maximum of compression of 76.2 ± 2.6% and a stress resistance of 3.1 kPa (Table 1, S18 Fig). We assume that these strong differences are not only caused by the composition of the hydrogels and the structure of the different monomers but also that the shape of the specimen strongly affects the maximum of compression. The friction at the jaw inserts leads to shear stresses putting the sample into hydrostatic compression. Thus, properties at high compressive strain in compression should not be considered directly comparable to a true strength.[29] Therefore, the mechanical properties of hydrogels with different sample shapes are difficult to compare.

Fig 4. Compression curves of A various hydrogels [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%]; B poly(MAE-TMA) with different CL [22 ± 2 °C; n ≥ 3; M: 2 mol/L; CL: 2 mol%]; C poly(MAE-TMA) with different M amounts [22 ± 2 °C; n ≥ 3; MBAA: 2 mol%] and D poly(MAE-TMA) with different MBAA amounts [22 ± 2 °C; n ≥ 3; M: 2 mol/L].

Fig 4

Table 1. Comparison of the compression, the stress-at-break, the equilibrium degrees of swelling and the cell adhesion with different M and CL ratios.

CL Hydrogel M [mol%] CL [mol%] Compression [%] Stress-at-break [kPa] qt [] Cell adhesion
MBAA poly(AE-SO3) 2 2 72.8 ± 1.7 1.8 5.8 ± 0.2 ++
poly(MAE-SO3) 2 2 59.7 ± 0.8 1.0 8.9 ± 0.4 ++
poly(VEtImBr) 2 2 53.1 ± 0.7 0.4 3.7 ± 0.1 +
poly(TMA-VB) 2 2 88.8 ± 1.2 3.2 20.8 ± 2.8 0
poly(AE-TMA) 2 2 77.6 ± 0.7 5.9 8.6 ± 0.2 ++
poly(MPC) 2 2 82.4 ± 0.8 3.2 3.8 ± 0.3 +
poly(MAEDMA-SO3) 2 2 83.3 ± 1.4 4.6 0.1 ± 0.1 0
poly(AAMPSO3H) 2 2 57.6 ± 1.8 1.0 5.9 ± 0.2 +
poly(HPMAA) 2 2 62.6 ± 0.4 0.8 2.6 ± 0.1 +
poly(HEMA) 2 2 76.2 ± 2.6 3.1 0.3 ± 0.2 0
poly(MAE-TMA) 2 1 81.9 ± 1.3 1.3 16.8 ± 5.9 *
2 2 73.1 ± 0.4 0.7 13.7 ± 0.6 +
2 3 46.6 ± 0.6 0.6 5.3 ± 0.7 *
2 4 35.0 ± 0.3 0.9 4.4 ± 0.7 *
1 2 98.5 ± 0.5 0.2 30.2 ± 0.2 *
1.5 2 83.3 ± 0.7 0.7 21.0 ± 1.9 *
2.5 2 78.3 ± 1.3 1.8 10.9 ± 1.6 *
EGDA 2 2 51.7 ± 2.0 0.3 13.6 ± 1.1 *
PEGDA Mn = 250 2 2 73.3 ± 0.6 0.5 15.1 ± 2.8 *
PEGDA Mn = 575 2 2 84.2 ± 0.9 0.9 21.6 ± 1.0 *
PEGDA Mn = 700 2 2 89.6 ± 0.6 1.6 27.6 ± 2.9 *

(n≥3),

* = not tested, degree of swelling and compression diagrams that are not shown in the manuscript are listed in the SI.

The monomer MAE-TMA was chosen for the further investigations of the hydrogel properties depending on the crosslinker and concentration of the monomer or crosslinker, since its mechanical and swelling properties are in the average of the other hydrogels in this study. Fig 4B shows the dependence of the hydrogel poly(MAE-TMA) with different crosslinker types. The mechanical properties change slightly with the lengths of the crosslinker PEGDA. The shorter the PEGDA crosslinker chain, the stiffer the obtained hydrogel. When using PEGDA 700 as a crosslinker the most compressibility (89.6 ± 0.6%) and highest force resistance (1.6 kPa) could be observed. In general, the shapes of the compression curves are very similar, indicating an influence of the type of monomer and the hydrogel composition. Fig 4C describes the influence of the monomer concentration on the mechanical properties of poly(MAE-TMA). While poly(MAE-TMA) with a monomer amount of 1 mol/L shows a maximum of compression of 98.5 ± 0.5% and a stress-at-break of 0.2 kPa, the stress-at-break increases to 1.8 kPa at 2.5 mol/L. However, the maximum of compression decreases to 78.3 ± 1.3%. In consequence, the maximum of compression is higher at a lower monomer concentration. Additionally, the mechanical properties of hydrogels can be regulated by using different crosslinker amounts. Part D Fig 4. shows the relationship between crosslinker concentration and mechanical properties. The higher the crosslinker density, the stiffer and more brittle the resulting hydrogels become. The increasing crosslinking leads to a tighter mesh tolerating less pressure.

Degree of swelling characterization

The equilibrium swelling studies of the synthesized hydrogels from various monomer starting materials at 37°C are shown in part A of Fig 5 and were performed in distilled water. Poly(TMA-VB) reaches a degree of swelling up to 20 within 120 min. However, the equilibrium of swelling can be achieved in a range of 30 min (poly(MPC)) up to 120 min (poly(TMA-VB)) (Table 1, S20 Fig), depending on the monomer. In general, the obtained degree of swelling of the hydrogels can be divided into a strong and a slight swelling. The strongly swelling hydrogels include poly(TMA-VB) and poly(MAE-TMA) whereas poly(AE-SO3), poly(MAE-SO3), poly(VEtImBr), poly(AE-TMA), poly(MPC), poly(HEMA), poly(HPMAA), poly(MAEDMA-SO3) and poly(AAMPSO3H) are categorized as slightly swelling hydrogels. The influence of the additional methyl group is also reflected in the swelling properties of the poly(MAE-TMA) and poly(AE-TMA) as well as poly(MAE-SO3) and poly(AE-SO3), leading to a higher degree of swelling with an additional methyl group (Fig 5A).

Fig 5. Swelling kinetics of A various hydrogels [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%]; B poly(MAE-TMA) with different CL [22 ± 2 °C; n ≥ 3; M: 2 mol/L; CL: 2 mol%]; C poly(MAE-TMA) with different M amounts [22 ± 2 °C; n ≥ 3; MBAA: 2 mol%] and D poly(MAE-TMA) with different MBAA amounts [22 ± 2 °C; n ≥ 3; M: 2 mol/L].

Fig 5

Different parameters influence the hydrogel swelling, such as the thermodynamic compatibility, polymer relaxation time, the solvent motion and interaction with the functional groups of the hydrogel as well as the crosslinker chain lengths. The degree of swelling dependency of poly(MAE-TMA) on the crosslinker were compared in Fig 5B. The chemical properties of the crosslinkers have a significant effect on the swelling behavior. For instance, the hydrophilic crosslinker PEGDA is compensating the loss of hydrophilic character during the polymerization of the backbone.[30] In addition, a major factor influencing the degree of swelling has been found to be the monomer concentration in the hydrogel. Fig 5C shows the monomer dependence of poly(MAE-TMA) from 1 to 2.5 mol/L. Another dependency factor for the degree of swelling is the crosslinker amount (Fig 5D). Both the degree of swelling and the diffusion rate vary significantly. In general, the higher the crosslinker content or monomer amount, the lower the degree of swelling. In the example of poly(MAE-TMA), the degree of swelling decreases up to a crosslinker amount of 3 mol%. Interestingly, if the crosslinker concentration is further increased, the degree of swelling remains largely constant in equilibrium. The data for all hydrogels are compiled in Table 1 including the biocompatibility, which will be discussed in the following section.

Preparation of the specimen and biocompatibility of the presented hydrogels

In a preliminary study we reported an excellent in vitro biocompatibility of a whole range of hydrogels in eluate testing approaches.[31] However, this method only addresses cytotoxic effects of substances, which leach out of a material under physiological conditions and does not take the effect of the polymer surface on the cell adhesion and thus on cell growth and viability into consideration. So far, the materials to be examined have been placed on top of confluent cell layers to evaluate cell viability in direct contact.[32] In these studies, however, no conclusions can be drawn about how well a hydrogel allows for or even supports cell colonization. Such a hydrogel, utilized as a cell adherent coating on implants, might be invaluable to prevent foreign body reactions and the corresponding severe complications in various organs.[3337] For the development of an on top direct contact test, a suitable method for the production of suitable specimens had to be devised first. The foremost requirements on the specimen were a smooth and flat surface as well as volume and shape stability. In addition, they must ensure a horizontal positioning for homogenous cell distribution. Neither the cutting of specimens from hydrogels polymerized in cylindrical form nor the direct polymerization in the 96 well plates were able to provide this. In cell cultivation experiments, hardly any cells could be cultivated on the hydrogels. The solution for this problem was the utilization of two 50 mm diameter cover slips. The hydrogel test specimens, which were polymerized between these cover glasses, had, due to the capillary forces between the glasses, the required minimum layer thickness and a sufficiently suitable smooth surface. In order to prevent volume and shape changes of the swollen specimens during the experiment, cell culture medium was used instead of distilled water as the swelling medium. In preliminary tests, the use of distilled water resulted in a change in volume and shape of the specimens in the well. The specimen shrunk so that the cells did not attach on the hydrogel but on the polystyrene beside it. The herein described developed procedure finally allowed us to evaluate cell viability quantitatively and qualitatively with an on top direct contact test technique.

In general, most of the tested hydrogels exhibit excellent biocompatibility in direct contact. With 98.4% relative cell viability poly(VEtImBr) achieved the best result in quantitative cell viability assay. The hydrogels poly(AE-SO3), poly(MAE-SO3), poly(MAEDMA-SO3), poly(AAMPSO3H), poly(HEMA) and poly(MAE-TMA) did not reduce the cell vitality by more than 20%, which corresponds to a low cytotoxicity. Concerning their cell viability these hydrogels can compete with hyaluronic acid or alginate based hydrogels exhibiting long-standing clinical use (Fig 6).[38,39] Poly(TMA-VB) poly(MPC) poly(HPMAA) exhibited with around 70% cell viability a moderate cytotoxicity.

Fig 6. Relative cell viability of A poly(AE-TMA); B poly(MAE-SO3); C poly(AE-SO3); D poly(MPC); E poly(VEtImBr); F poly(MAE-TMA); G poly(HPMAA); H poly(AAMPSO3H); I poly(TMA-VB); J poly(MAEDMA-SO3) and K poly(HEMA) was determined by the Cell Quanti Blue assay.

Fig 6

The relative cell vitality is determined by the ratio of the averaged fluorescence intensity in the hydrogel samples to the polystyrene negative control (100%). To support the results of the test, tetraethylthiuram disulfide (TEDT) at a concentration of 1х10−4 mol/L was used as the positive control, n ≥ 3.

However, the determined cell viability is an indicator for the metabolic activity of the cell on the hydrogel and therefore only one aspect for the biological evaluation. In order to carry out normal metabolism activity, proliferation and differentiation, fibroblasts must attach to and spread on an underlying matrix.[40] We addressed these questioning with qualitative microscopic analysis. On seven hydrogel surfaces we found a remarkable L929 fibroblast cell growth. Moreover the cells on poly(AE-TMA), poly(AE-SO3) and poly(MAE-SO3) exhibited cell morphology typically for healthy fibroblasts, indicated an outstanding cell adhesion. The hydrogels poly(TMA-VB), poly(MPC), poly(HPMAA), poly(MAE-TMA) and poly(MAEDMA-SO3) created poor estimated cell densities and spherical shapes of the fibroblasts, indicating poor cell adhesion. The so occurring sharp differences between cell viability and the microscopic images for that hydrogels may be triggered by strong cell-cell-adhesion but weak cell-hydrogel-adhesion. This might result in detachment of the cells from the hydrogel surface due to movement of the cell culture dishes or cell culture media change. However, this only emphasizes the excellent suitability of poly(AE-TMA), poly(AE-SO3) and poly(MAE-SO3) as a matrix for cell growth (Fig 7).

Fig 7. Microscopic imaging with light microscopy (left) and Calcein AM staining for cytochemical analysis (right) of the hydrogels, n ≥ 3.

Fig 7

The cell adhesion, however, is not only mediated by the biological characteristics of the cells, but also chemophysical properties of both, cells and material, play an essential role. Positively charged materials are preferred by fibroblast cells due to their negatively charged membrane.[41] Nonetheless, several studies have demonstrated an enhanced cell adhesion and spreading on hydrophilic surfaces compared to hydrophobic surfaces.[42,43] In aqueous systems, charged materials are obviously preferable, independent from the type of charge.

Moreover, the matrix morphology plays an important role for the formation of a cell layer. Notably, the tested hydrogels with the lowest degree of swelling, such as poly(HEMA) and poly(MAEDMA-SO3) exhibit a poor cell adhesion, In addition, we observed the best cell adhesion on hydrogels with a swelling degree between 5 and 10 (poly(AE-SO3), poly(MAE-SO3), poly(AE-TMA)). In contrast to that, the hydrogels with an exceedingly high degree of swelling, such as poly(TMA-VB) have a poor cell adhesion. We assume, that the moderately swelling hydrogels form a porous surface, acting as an anchor for the fibroblast cell extensions. Moreover, a porous surface provides an enlarged surface-to-volume ratio and by this a more enhanced binding of membrane associated adhesion molecules via hydrogen bonds. Regarding strongly swelling hydrogels, the pore sizes probably exceed the appropriate size what finally results in the loss of the anchor function and subsequently leads to a reduction of hydrogen bonds.

However, when investigating materials for an application of the body, not only direct biocompatibility has to be ensured, but in addition possible toxic or harmful effects of degradation products have to be taken into account. The hydrogel materials in the presented work are based on functionalized methacrylate monomers crosslinked with MBAA. This compound class has shown no or little cytotoxic degradation products in literature.[4446] However, since different functionalities such as sulfonic acid or amino groups may have a huge impact on the biocompatibility, especially of degradation products, this behavior has to be investigated before application testing in vivo and regarding potential approval processes for biomedical uses. Another aspect for potential approval processes is the immunotoxicity of the body to different kind of materials. In literature we found evidence for inflammatory processes in vitro and in vivo caused by hydrogels. Amer et al. reported about an toll-like receptor mediated activation of macrophages on synthetic poly (ethylene glycol) hydrogels.[47] To select suitable hydrogels for specific biomedical applications, this materials should additionally be tested for their potential to induce apoptosis.

Summary and conclusion

Hydrogel materials derived from ionic liquids were successfully synthesized by radical polymerization of electrolytes bearing a vinyl group using MBAA and PEGDA as crosslinkers. In addition, mechanical characteristics and degree of swelling of these hydrogels and biocompatibility of the MBAA hydrogels were investigated. Our findings show that the properties of the yielded hydrogels depend on the method of preparation, polymer volume fraction, crosslinking degree, crosslinker chain length and swelling agent. The mechanical properties of the hydrogels are mainly controlled by the type of monomer and are only slightly reliant on the type of crosslinker. Desired mechanical properties are achieved by simple adjustment of the monomer and crosslinker concentration. This is practically limited by the solubility of the type of monomer and crosslinker. A new protocol to obtain hydrogel specimens for direct contact testing the biocompatibility has been shown. Direct contact testing revealed a good cell viability for the predominant part of the hydrogels competing with natural compound based polymers in longstanding clinical use.[38,39] A selection of the investigated hydrogels revealed an excellent in vitro biocompatibility and therefore proved their suitability for utilization in biomedical applications. Furthermore, a dependency on the degree of swelling on the cell viability has been shown. In summary, for biomedical application of hydrogels not only eluate untoxicity must been taken into account but also the effect of the surface morphology of hydrogels on the cell growth and viability.

Supporting information

S1 Fig. IR-spectrum of poly(AAMPSO3H) with MBAA as a crosslinker.

3323 cm-1 (OH, w, moisture); 2951 cm-(C-H, d); 1650 cm-1 (C = O, s); 1539 cm-1 (N-H, s); 1186 cm-1 (SO3-, s); 1043 cm-1 (SO3-, s); 624 cm-1 (C-CO-C, s) cm-1 (C-S, w).

(TIF)

S2 Fig. IR-spectrum of poly(AE-SO3) with MBAA as a crosslinker.

3418 cm-1 (OH, w, moisture); 2936 cm-1 (C-H, d); 1720 cm-1 (C = O, s); 1158 cm-1 (SO3-, s); 1036 cm-1 (SO3-, s); 607 cm-1 (C-CO-C, s); 523 cm-1 (C-S, w).

(TIF)

S3 Fig. IR-spectrum of poly(AE-TMA) with MBAA as a crosslinker.

3360 cm-1 (OH, w, moisture); 2954 cm-1 (C-H, d); 1724 cm-1 (C = O, s); 1479 cm-1 (CH2, s); 1158 cm-1 (C-O, s); 952 cm-1 (C-CO-C, s).

(TIF)

S4 Fig. IR-spectrum of poly(HPMAA) with MBAA as a crosslinker.

3327 cm-1 (OH, w); 2971 cm-1 (C-H, d);1634 cm-1 (C = O, s); 1522 cm-1 (N-H, s).

(TIF)

S5 Fig. IR-spectrum of poly(MAEDMA-SO3) with MBAA as a crosslinker.

3420 cm-1 (OH, moisture); 2961 cm- (C-H, d); 1720 cm-1 (C = O, s); 1648 cm-1 (C = O, s); 1478 cm-1 (N-H, s); 1153 cm-1 (SO3-, s); 1030 cm-1 (SO3-, s); cm-1 (C-CO-C, s); 521 cm-1 (C-S, w).

(TIF)

S6 Fig. IR-spectrum of poly(MAE-SO3) with MBAA as a crosslinker.

3441 cm-1 (OH, w, moisture); 2944 cm-1 (C-H, d); 1716 cm-1 (C = O, s); 1156 cm-1 (SO3-, s); 1038 cm-1 (SO3-, s); 609 cm-1 (C-CO-C, s); 523 cm-1 (C-S, w).

(TIF)

S7 Fig. IR-spectrum of poly(MAE-TMA) with MBAA as a crosslinker.

3358 cm-1 (OH, w, moisture); 3022 cm-1 (C-H, d); 1718 cm-1 (C = O, s); 1636 cm-1 (C = O, s);1475 cm-1 (CH2, s); 1147 cm-1 (C-O, s); 949 cm-1 (C-CO-C, s).

(TIF)

S8 Fig. IR-spectrum of poly(VEtImBr) with MBAA as a crosslinker.

3439 cm-1 (OH, w, moisture); 2944 cm-1 (C-H, d); 1714 cm-1 (C = O, s); 1473 cm-1 (N-H, s);1453 cm-1 (CH2, s); 1156 cm-1 (C-C-N, s); 737 cm-1 (C-CO-C, s).

(TIF)

S9 Fig. IR-spectrum of poly(TMA-VB) with MBAA as a crosslinker.

3232 cm-1 (OH, w, moisture); 2963 cm-1 (= C-H, m); 1642 cm-1 (-C = C, s); 1477 cm-1 (-C = C, s); 1261 cm-1 (CH3, s); 1092 cm-1 (C -N, s); 890 cm-1 (= C-H, s).

(TIF)

S10 Fig. IR-spectrum of poly(MPC) with MBAA as a crosslinker.

3340 cm-1 (OH, w, moisture); 1716 cm-1 (C-O, d); 1479 cm-1 (CH3, s); 1228 cm-1 (C-C-N, s); 1057 cm-1 (P-O, s); 954 cm-1 (C-N, s); 921 cm-1 (P-O, s); 783 cm- (C-CO-C, s).

(TIF)

S11 Fig. IR-spectrum of poly(HEMA) with MBAA as a crosslinker.

3336 cm-1 (OH, w); 2961 cm-1 (C-H, d); 1706 cm-1 (C = O, s); 1632 cm-1 (C = O, s); 1448 cm-1 (CH2, s); 1261 cm-1 (C-O-C, s); 1158 cm-1 (CH3, s); 1073 cm-1 (); 892 cm-1 (C-CO-C, s).

(TIF)

S12 Fig. IR-spectrum of poly(MAE-TMA) with 700 PEGDA as a crosslinker.

3362 cm-1 (OH, w, moisture);2963 cm-1 (C-H, d); 1720 cm-1 (C = O, s); 1634 cm-1 (C = O, s);1475 cm-1 (CH2, s); 1230 cm-1 (C-O, s); 947 cm-1 (C-CO-C, s).

(TIF)

S13 Fig. Compression curve of poly(VEtImBr) with MBAA as a crosslinker [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%].

(TIF)

S14 Fig. Compression curve of poly(MAEDMA-SO3) with MBAA as a crosslinker [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%].

(TIF)

S15 Fig. Compression curve of poly(MPC) with MBAA as a crosslinker [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%].

(TIF)

S16 Fig. Compression curve of poly(AAMPSO3H) with MBAA as a crosslinker [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%].

(TIF)

S17 Fig. Compression curve of poly(HPMAA) with MBAA as a crosslinker [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%].

(TIF)

S18 Fig. Compression curve of poly(HEMA) with MBAA as a crosslinker [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%].

(TIF)

S19 Fig. Compression curve of poly(VEtImBr) with MBAA as a crosslinker [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%].

(TIF)

S20 Fig. Compression curve of poly(MPC) with MBAA as a crosslinker [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%].

(TIF)

S21 Fig. Compression curve of poly(AAMPSO3H) with MBAA as a crosslinker [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%].

(TIF)

S22 Fig. Compression curve of poly(HPMAA) with MBAA as a crosslinker [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%].

(TIF)

S23 Fig

(TIF)

S1 Data

(PDF)

Acknowledgments

We thank Katrin Feest, Jan von Langermann and Lars-Erik Meyer for proof reading this paper. We also thank Sandra Diederich and Daniela Arbeiter for their technical support.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

We acknowledge financial support by Deutsche Forschungsgemeinschaft and University of Rostock within the funding programme Open Access Publishing. Funding by the Federal Ministry of Education and Research within RESPONSE "Partnership for Innovation in Implant Technology" (FKZ 03ZZ0910B) is gratefully acknowledged.

References

  • 1.de Queiroz AAB, Debieux P, Amaro J, Ferretti M, Cohen M. Hydrogel implant is as effective as osteochondral autologous transplantation for treating focal cartilage knee injury in 24 months. Knee Surgery, Sport Traumatol Arthrosc. 2018;26: 1–8. 10.1007/s00167-018-4834-5 [DOI] [PubMed] [Google Scholar]
  • 2.Colter J, Wirostko B, Coats B. Finite Element Design Optimization of a Hyaluronic Acid-Based Hydrogel Drug Delivery Device for Improved Retention. Ann Biomed Eng. 2018;46: 211–221. 10.1007/s10439-017-1962-x [DOI] [PubMed] [Google Scholar]
  • 3.Kamaly N, Yameen B, Wu J, Farokhzad OC. Degradable controlled-release polymers and polymeric nanoparticles: Mechanisms of controlling drug release. Chem Rev. 2016;116: 2602–2663. 10.1021/acs.chemrev.5b00346 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Sun H, Yang H, Huang W, Zhang S. Immobilization of laccase in a sponge-like hydrogel for enhanced durability in enzymatic degradation of dye pollutants. J Colloid Interface Sci. 2015;450: 353–360. 10.1016/j.jcis.2015.03.037 [DOI] [PubMed] [Google Scholar]
  • 5.Behl G, Iqbal J, O’Reilly NJ, McLoughlin P, Fitzhenry L. Synthesis and Characterization of Poly(2-hydroxyethylmethacrylate) Contact Lenses Containing Chitosan Nanoparticles as an Ocular Delivery System for Dexamethasone Sodium Phosphate. Pharm Res. 2016;33: 1638–1648. 10.1007/s11095-016-1903-7 [DOI] [PubMed] [Google Scholar]
  • 6.Claus J, Sommer FO, Kragl U. Ionic liquids in biotechnology and beyond. Solid State Ionics. 2018;314: 119–128. 10.1016/j.ssi.2017.11.012 [DOI] [Google Scholar]
  • 7.Okay O. Hydrogel Sensors and Actuators vol 6 Hydrogel Sensors and Actuators Springer Series on Chemical Sensors and Biosensors (Methods and Applications). vol 6. Berlin, Heidelberg: Springer; 2009. [Google Scholar]
  • 8.Bingol B, Altuncu S, Demir Duman F, Ak A, Gulyuz U, Yagci Acar H, et al. One-Step Injectable and Bioreducible Poly(B-Amino Ester) Hydrogels As Controlled Drug Delivery Platforms. ACS Appl Polym Mater. 2019;1: 1724–1734. 10.1021/acsapm.9b00287 [DOI] [Google Scholar]
  • 9.Su E, Yurtsever M, Okay O. A Self-Healing and Highly Stretchable Polyelectrolyte Hydrogel via Cooperative Hydrogen Bonding as a Superabsorbent Polymer. Macromolecules. 2019;52: 3257–3267. 10.1021/acs.macromol.9b00032 [DOI] [Google Scholar]
  • 10.Bandomir J, Schulz A, Taguchi S, Schmitt L, Ohno H, Sternberg K, et al. Synthesis and Characterization of Polymerized Ionic Liquids: Mechanical and Thermal Properties of a Novel Type of Hydrogels. Macromol Chem Phys. 2014;215: 716–724. 10.1002/macp.201400009 [DOI] [Google Scholar]
  • 11.Verma AS, FitzPatrick DR. Anophthalmia and microphthalmia. Orphanet J Rare Dis. 2007;2: 1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Mazzoli RA, Raymond WR, Ainbinder DJ, Hansen EA. Use of self-expanding, hydrophilic osmotic expanders (hydrogel) in the reconstruction of congenital clinical anophthalmos. Curr Opin Ophthalmol. 2004;15: 426–431. 10.1097/01.icu.0000138618.61059.4c [DOI] [PubMed] [Google Scholar]
  • 13.Smit TJ, Koornneef L, Zonneveld FW, Groet E, Otto AJ. Management of acquired anophthalmos: A historical review. Orbit. 1991;10: 63–76. 10.3109/01676839109023086 [DOI] [Google Scholar]
  • 14.Taksali S, Grauer JN, Vaccaro AR. Material considerations for intervertebral disc replacement implants. Spine J. 2004;4: S231–S238. 10.1016/j.spinee.2004.07.012 [DOI] [PubMed] [Google Scholar]
  • 15.Darwis D, Stasica P, Razzak MT, Rosiak JM. Characterization of poly(vinyl alcohol) hydrogel for prosthetic intervertebral disc nucleus. Radiat Phys Chem. 2002;63: 539–542. 10.1016/S0969-806X(01)00636-3 [DOI] [Google Scholar]
  • 16.Lu J, Yan F, Texter J. Advanced applications of ionic liquids in polymer science. Prog Polym Sci. 2009;34: 431–448. 10.1016/j.progpolymsci.2008.12.001 [DOI] [Google Scholar]
  • 17.Deguchi Y, Kohno Y, Ohno H. Reversible water uptake/release by thermoresponsive polyelectrolyte hydrogels derived from ionic liquids. Chem Commun. 2015;51: 9287–9290. 10.1039/c5cc02189h [DOI] [PubMed] [Google Scholar]
  • 18.Okafuji A, Kohno Y, Ohno H. Thermoresponsive Poly(Ionic Liquid)s in Aqueous Salt Solutions: Salting-Out Effect on Their Phase Behavior and Water Absorption/Desorption Properties. Macromol Rapid Commun. 2016;37: 1130–1134. 10.1002/marc.201500752 [DOI] [PubMed] [Google Scholar]
  • 19.Jamadi M, Shokrollahi P, Houshmand B, Joupari MD, Mashhadiabbas F, Khademhosseini A, et al. Poly (Ethylene Glycol)-Based Hydrogels as Self-Inflating Tissue Expanders with Tunable Mechanical and Swelling Properties. Macromol Biosci. 2017;17: 1–13. 10.1002/mabi.201600479 [DOI] [PubMed] [Google Scholar]
  • 20.Motta A, Migliaresi C, Faccioni F, Torricelli P, Fini M, Giardino R. Fibroin hydrogels for biomedical applications: preparation, characterization and in vitro cell culture studies. J Biomater Sci Polym Edn. 2012;15: 851–864. 10.1163/1568562041271075 [DOI] [PubMed] [Google Scholar]
  • 21.Marcilla R, Alberto Blazquez J, Rodriguez J, Pomposo JA, Mecerreyes D. Tuning the solubility of polymerized ionic liquids by simple anion-exchange reactions. J Polym Sci Part A Polym Chem. 2004;42: 208–212. 10.1002/pola.11015 [DOI] [Google Scholar]
  • 22.Fairbanks BD, Thissen H, Maurdev G, Pasic P, White JF, Meagher L. Inhibition of Protein and Cell Attachment on Materials Generated from N-(2-Hydroxypropyl) Acrylamide. Biomacromolecules. 2014;15: 3259–3266. 10.1021/bm500654q [DOI] [PubMed] [Google Scholar]
  • 23.Yanfeng C, Min Y. Swelling kinetics and stimuli-responsiveness of poly(DMAEMA) hydrogels prepared by UV-irradiation. Radiat Phys Chem. 2001;61: 65–68. 10.1016/S0969-806X(00)00374-1 [DOI] [Google Scholar]
  • 24.De Feng X, Guo XQ, Kun YQ. Study of the initiation mechanism of the vinyl polymerization with the system persulfate/ N,N,N ‘,N ‘-tetramethylethylenediamin. Macromol Chem. 1988;189: 77–83. [Google Scholar]
  • 25.Strachota B, Matějka L, Zhigunov A, Konefał R, Spěváček J, Dybal J, et al. Poly(N-isopropylacrylamide)-clay based hydrogels controlled by the initiating conditions: Evolution of structure and gel formation. Soft Matter. 2015;11: 9291–9306. 10.1039/c5sm01996f [DOI] [PubMed] [Google Scholar]
  • 26.Tanaka T, Hocker LO, Benedek GB. Spectrum of light scattered from a viscoelastic gel Spectrum of light scattered from a viscoelastic gel. J Chem Phys. 1991;59: 5151–5159. 10.1063/1.1680734 [DOI] [Google Scholar]
  • 27.Kaufman JD, Miller GJ, Morgan EF, Klapperich CM. Time-dependent mechanical characterization of poly(2-hydroxyethyl methacrylate) hydrogels using nanoindentation and unconfined compression. J Mater Res. 2008;23: 1472–1481. 10.1557/JMR.2008.0185 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hu X, Feng L, Wei W, Xie A, Wang S, Zhang J, et al. Synthesis and characterization of a novel semi-IPN hydrogel based on Salecan and poly(N,N-dimethylacrylamide-co-2-hydroxyethyl methacrylate). Carbohydr Polym. 2014;105: 135–144. 10.1016/j.carbpol.2014.01.051 [DOI] [PubMed] [Google Scholar]
  • 29.Calvert P. Hydrogels for soft machines. Adv Mater. 2009;21: 743–756. 10.1002/adma.200800534 [DOI] [Google Scholar]
  • 30.Lee KY, M. DJ. Alginate: properties and biomedical applications. Prog Polym Sci. 2013;37: 106–126. 10.1016/j.progpolymsci.2011.06.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Brietzke A, von der Ehe C, Illner S, Matschegewski C, Grabow N, Kragl U. Promising biocompatible hydrogels of crosslinked polyelectrolytes for biomedical applications. Curr Dir Biomed Eng. 2017;3: 695–698. 10.1515/cdbme-2017-0147 [DOI] [Google Scholar]
  • 32.Tummala GK, Lopes VR, Mihranyan A, Ferraz N. Biocompatibility of nanocellulose-reinforced PVA hydrogel with human corneal epithelial cells for ophthalmic applications. J Funct Biomater. 2019;10 10.3390/jfb10030035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Sigler M, Paul T, Grabitz RG. Biocompatibility screening in cardiovascular implants. Z Kardiol. 2005;94: 383–391. 10.1007/s00392-005-0231-4 [DOI] [PubMed] [Google Scholar]
  • 34.Tognetto D, Sanguinetti G, Ravalico G. Tissue reaction to hydrophilic intraocular lenses. Expert Rev Med Devices. 2005;2: 57–60. 10.1586/17434440.2.1.57 [DOI] [PubMed] [Google Scholar]
  • 35.Trindade R, Albrektsson T, Wennerberg A. Current Concepts for the Biological Basis of Dental Implants: Foreign Body Equilibrium and Osseointegration Dynamics. Oral Maxillofac Surg Clin North Am. 2015;27: 175–183. 10.1016/j.coms.2015.01.004 [DOI] [PubMed] [Google Scholar]
  • 36.Trindade R, Albrektsson T, Tengvall P, Wennerberg A. Foreign Body Reaction to Biomaterials: On Mechanisms for Buildup and Breakdown of Osseointegration. Clin Implant Dent Relat Res. 2016;18: 192–203. 10.1111/cid.12274 [DOI] [PubMed] [Google Scholar]
  • 37.Rayahin JE, Gemeinhart RA. Activation of Macrophages in Response to Biomaterials vol 62 Kloc M (eds) Macrophages Results and Problems in Cell Differentiation. vol 62. Springer, Cham; 2017. pp. 317–351. [DOI] [PubMed] [Google Scholar]
  • 38.Highley CB, Prestwich GD, Burdick JA. ScienceDirect Recent advances in hyaluronic acid hydrogels for biomedical applications. Curr Opin Biotechnol. 2016;40: 35–40. 10.1016/j.copbio.2016.02.008 [DOI] [PubMed] [Google Scholar]
  • 39.Yong K, Mooney DJ. Progress in Polymer Science Alginate: Properties and biomedical applications. Prog Polym Sci. 2012;37: 106–126. 10.1016/j.progpolymsci.2011.06.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Mrksich M. A surface chemistry approach to studying cell adhesion. Chem Soc Rev. 2000;29: 267–273. 10.1039/a705397e [DOI] [Google Scholar]
  • 41.Bongrand P, Capo C, Depieds R. Physics of cell adhesion. Prog Surf Sci. 1982;12: 217–285. 10.1016/0079-6816(82)90007-7 [DOI] [Google Scholar]
  • 42.Altankov G, Groth T. Reorganization of substratum-bound fibronectin on hydrophilic and hydrophobic materials is related to biocompatibility. J Mater Sci Mater Med. 1994;5: 732–737. 10.1007/BF00120366 [DOI] [Google Scholar]
  • 43.Chang S, Wang Y, Lin L, Kuo S. Studies of Cell Adhesion and Growth on Different Material Surfaces by Using a Flow Chamber. J Med Biol Eng. 2000;20: 6–7. [Google Scholar]
  • 44.Cui Z, Lee BH, Pauken C, Vernon BL. Degradation, cytotoxicity, and biocompatibility of NIPAAm-based thermosensitive, injectable, and bioresorbable polymer hydrogels. J Biomed Mater Res—Part A. 2011;98 A: 159–166. 10.1002/jbm.a.33093 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Ma Z, Nelson DM, Hong Y, Wagner WR. Thermally responsive injectable hydrogel incorporating methacrylate- polylactide for hydrolytic lability. Biomacromolecules. 2010;11: 1873–1881. 10.1021/bm1004299 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Moghadam MN, Pioletti DP. Biodegradable HEMA-based hydrogels with enhanced mechanical properties. J Biomed Mater Res—Part B Appl Biomater. 2016;104: 1161–1169. 10.1002/jbm.b.33469 [DOI] [PubMed] [Google Scholar]
  • 47.Amer LD, Saleh LS, Walker C, Thomas S, Janssen WJ, Alper S, et al. Inflammation via myeloid differentiation primary response gene 88 signaling mediates the fibrotic response to implantable synthetic poly(ethylene glycol) hydrogels. Acta Biomater. 2019;100: 105–117. 10.1016/j.actbio.2019.09.043 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Feng Zhao

7 Feb 2020

PONE-D-19-34741

Swelling characteristics and biocompatibility of ionic liquid based hydrogels for biomedical applications

PLOS ONE

Dear Prof. Dr. Kragl,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Mar 23 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Feng Zhao

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf and http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This research paper prepared various types of polyionic hydrogels using the same crosslinkers and initiators. The difference of mechanical properties, swelling ratio and biocompatibility among different composition of hydrogels were compared. The correlation of mechanical properties and biocompatibility to composition, cross-linkers and monomers concentrations of hydrogels were assessed. This paper provided a good mechanism reference for hydrogels synthesis and their potential applications.

Comments for minor revisions include spell checking (typos happened, e.g. line 239 should be "cells did not "attach" on the hydrogel"); supplementary results were not described in the main text.

Reviewer #2: In the current work, hydrogel materials derived from ionic liquids were successfully synthesized by radical polymerization of electrolytes bearing a vinyl group using MBAA and PEGDA as crosslinkers. The mechanical characteristics, degree of swelling and biocompatibility of the MBAA hydrogels were investigated. Although impressive, following issues needs to be addressed to make the manuscript technically sound.

1. The information regarding statistical analysis is missing.

2. Line 122: Please include the seeding density of the L929 mouse fibroblast per well of the 96-well plate.

3. Line 112: How much hydrogel (or how many milliliters) was added between two 50 mm diameter cover glass for the biocompatibility assay?

4. Clearly explain how the dead cells were quantified? and compared with which CONTROL to calculate relative cell viability (Fig. 6).

5. Line 256-257: "The hydrogels poly(TMA-VB), poly(MPC), poly(HPMAA), poly(MAE-TMA) and poly(MAEDMA-SO3) created poor cell counts and spherical shapes of the fibroblasts, indicating poor cell adhesion" : Explain how the cells were counted and compared with which control?

Here, the poor cell counts can be result from two reasons: (1) Lower cellular adhesion property of the hydrogel itself (due to difference in porosity or swelling, as discussed by the authors) and/or (2) Hydrogel induced cytotoxicity that allows cells to initially attach on the hydrogel surface, BUT due to the cytotoxic hydrogel components, cells undergo apoptosis and finally detach from the hydrogel surface. To prove that the hydrogel ITSELF is not cytotoxic, it is important to perform ethidium homodimer-1 (EtHD-1) staining along with calcein-AM. EtHD-1 can detect the hydrogel-attached apoptotic cells to determine whether hydrogel itself is cytotoxic or not. Please address and discuss this issue.

6. No information regarding degradation rate of these hydrogel is provided. Since these hydrogels are proposed to be used for biomedical applications, it is very critical to study their rate of degradation.

7. Please include discussion regarding the immune cell response (especially macrophages) toward these hydrogels if previously reported in the literature. Importantly, discuss whether the degradation products of these hydrogel can induce severe immune response.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Apr 20;15(4):e0231421. doi: 10.1371/journal.pone.0231421.r002

Author response to Decision Letter 0


24 Feb 2020

Response to Reviewer

Swelling characteristics and biocompatibility of ionic liquid based hydrogels for biomedical applications

PONE-D-19-34741

Reviewer #1

Reviewer #1: This research paper prepared various types of polyionic hydrogels using the same crosslinkers and initiators. The difference of mechanical properties, swelling ratio and biocompatibility among different composition of hydrogels were compared. The correlation of mechanical properties and biocompatibility to composition, cross-linkers and monomers concentrations of hydrogels were assessed. This paper provided a good mechanism reference for hydrogels synthesis and their potential applications.

Comments for minor revisions include spell checking (typos happened, e.g. line 239 should be "cells did not "attach" on the hydrogel"); supplementary results were not described in the main text.

Response from the authors: Thank you for this useful hint. Some spelling mistakes where found and corrected. Additional references to the Supporting information have been added, e.g. line 164, line 171, line 195-196, line 200-201.

Reviewer #2

Reviewer #2: In the current work, hydrogel materials derived from ionic liquids were successfully synthesized by radical polymerization of electrolytes bearing a vinyl group using MBAA and PEGDA as crosslinkers. The mechanical characteristics, degree of swelling and biocompatibility of the MBAA hydrogels were investigated. Although impressive, following issues needs to be addressed to make the manuscript technically sound.

1. The information regarding statistical analysis is missing.

Response from the authors: Thank you for this comment.

We have modified the manuscript accordingly. In line 127-128 we added the sentences: “Replicates (n ≥ 3) were tested for normal distribution and subjected to a Nalimovs’ test for outliers. Means and standard errors (SEM) were calculated in Sigma Plot.” In addition, the missing number of replicates (n ≥ 3) are added to Fig. 6 and Fig. 7.

2. Line 122: Please include the seeding density of the L929 mouse fibroblast per well of the 96-well plate.

Response from the authors: Thank you for this comment. We added this information in our manuscript at line 122-123: “1x104 L929 mouse fibroblasts were seeded directly on the hydrogel specimen with 200 µL culture medium per well and incubated under cell culture conditions (37°C, 5% CO2) for 46 hours (fibroblast cell density 62500 cells x cm2).”

3. Line 112: How much hydrogel (or how many milliliters) was added between two 50 mm diameter cover glass for the biocompatibility assay?

Response from the authors: The information has been added to the materials and methods part of the manuscript (line 112): “For biocompatibility testing, 1 mL of the monomer-crosslinker solution was polymerized between two 50 mm diameter cover slips to obtain specimen with the maximum possible surface.”

4. Clearly explain how the dead cells were quantified? and compared with which CONTROL to calculate relative cell viability (Fig. 6).

Response from the authors: Thank you for this hint. We extended the legend of Figure 6 in line 251 to: “Relative cell viability of A poly(AE-TMA); B poly(MAE-SO3); C poly(AE-SO3); D poly(MPC); E poly(VEtImBr); F poly(MAE-TMA); G poly(HPMAA); H poly(AAMPSO3H); I poly(TMA-VB); J poly(MAEDMA-SO3) and K poly(HEMA) was determined by the Cell Quanti Blue assay. The relative cell viability is determined by the ratio of the averaged fluorescence intensity in the hydrogel samples to the polystyrene negative control (100%). To support the results of the test, tetraethylthiuram disulfide (TETD) at a concentration of 1х10-4 mol/L was used as the positive control.” Another part of the description has been removed as it refers to the synthesis conditions of the hydrogels.

Additionally we enhanced line 131: “Cells were stained with Calcein AM (Thermo Fisher Waltham, MA, USA) to prove the viability of the living cells.”

Additionally, we changed line 263-264 to: “The hydrogels poly(TMA-VB), poly(MPC), poly(HPMAA), poly(MAE-TMA) and poly(MAEDMA-SO3) created poor estimated cell densities and spherical shapes of the fibroblasts, indicating poor cell adhesion.”

5. Line 256-257: "The hydrogels poly(TMA-VB), poly(MPC), poly(HPMAA), poly(MAE-TMA) and poly(MAEDMA-SO3) created poor cell counts and spherical shapes of the fibroblasts, indicating poor cell adhesion" : Explain how the cells were counted and compared with which control?

Here, the poor cell counts can be result from two reasons: (1) Lower cellular adhesion property of the hydrogel itself (due to difference in porosity or swelling, as discussed by the authors) and/or (2) Hydrogel induced cytotoxicity that allows cells to initially attach on the hydrogel surface, BUT due to the cytotoxic hydrogel components, cells undergo apoptosis and finally detach from the hydrogel surface. To prove that the hydrogel ITSELF is not cytotoxic, it is important to perform ethidium homodimer-1 (EtHD-1) staining along with calcein-AM. EtHD-1 can detect the hydrogel-attached apoptotic cells to determine whether hydrogel itself is cytotoxic or not. Please address and discuss this issue.

Response from the authors:

Thank you very much for your detailed comment. Our microscopic analysis did not aim to provide a quantitative conclusion on cytotoxicity. Rather, it was intended to support the quantitative analysis with the CellQuanti Blue Assay. The microscopic images should prove that the cells were actually actively spreading on the hydrogel, displaying another quality of the hydrogels besides cell viability. In earlier experiments using a different preparation methods of the specimens, we found that the cells slipped off the hydrogel and grew on the cell culture polystyrene. Very good cell viability could be measured here as well.

Furthermore, we were able to make a qualitative evaluation of the cell morphology by microscopic analysis. The Calcein AM staining was also intended to demonstrate that the cells on the hydrogels are viable, but not to provide a quantification for the evaluation of cytotoxicity. The question of whether apoptotic or possibly also necrotic processes result in a reduction of cell count and cell viability is undoubtedly very interesting, but not the subject of this study. Rather, we intended to pre-select candidates from a whole range of hydrogels based on basic parameters. After selecting generally suitable hydrogels for specific biomedical applications, this materials should indeed be tested for their potential to induce apoptosis.

We added another paragraph to our manuscript (line 293-294): “To select suitable hydrogels for specific biomedical applications, this materials should additionally be tested for their potential to induce apoptosis.”

6. No information regarding degradation rate of these hydrogel is provided. Since these hydrogels are proposed to be used for biomedical applications, it is very critical to study their rate of degradation.

Response from the authors: The degradation of these hydrogels is certainly interesting and necessary for this type of application. We added a paragraph to our manuscript regarding this topic (line 285-290): “However, when investigating materials for an application of the body, not only direct biocompatibility has to be ensured, but in addition possible toxic or harmful effects of degradation products have to be taken into account. The hydrogel materials in the presented work are based on functionalized methacrylate monomers crosslinked with MBAA. This compound class has shown no or little cytotoxic degradation products in literature (44–46). However, since different functionalities such as sulfonic acid or amino groups may have a huge impact on the biocompatibility, especially of degradation products, this behavior has to be investigated before application testing in vivo and regarding potential approval processes for biomedical uses.”

However, these experiments and results would go beyond the scope of this manuscript but will be addressed in the ongoing work on this topic.

7. Please include discussion regarding the immune cell response (especially macrophages) toward these hydrogels if previously reported in the literature. Importantly, discuss whether the degradation products of these hydrogel can induce severe immune response.

Response from the authors:

Thank you for this interesting hint. In our response to comment 5 we already claimed that we intended to pre-select hydrogels for specific biomedical applications based on basic parameters. Nevertheless, aspects of the immunotoxicity are very interesting and must be addressed within approval process for biomedical applications. Indeed, we found evidence for inflammatory processes in vitro and in vivo caused by hydrogels in literature. For example Amer et al., 2019 found an Toll-like receptor mediated activation of macrophages on synthetic poly (ethylene glycol) hydrogels. We appreciate your advice and will consider this in our future studies.

We added a paragraph to our manuscript regarding this topic (line 290 – 293): “Another aspect for potential approval processes is the immunotoxicity of the body to different kind of materials. In literature we found evidence for inflammatory processes in vitro and in vivo caused by hydrogels. Amer et al. reported about an toll-like receptor mediated activation of macrophages on synthetic poly (ethylene glycol) hydrogels (47).”

Attachment

Submitted filename: Response to Reviewer.pdf

Decision Letter 1

Feng Zhao

24 Mar 2020

Swelling characteristics and biocompatibility of ionic liquid based hydrogels for biomedical applications

PONE-D-19-34741R1

Dear Dr. Kragl,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Feng Zhao

Academic Editor

PLOS ONE

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

Acceptance letter

Feng Zhao

7 Apr 2020

PONE-D-19-34741R1

Swelling characteristics and biocompatibility of ionic liquid based hydrogels for biomedical applications

Dear Dr. Kragl:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Feng Zhao

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. IR-spectrum of poly(AAMPSO3H) with MBAA as a crosslinker.

    3323 cm-1 (OH, w, moisture); 2951 cm-(C-H, d); 1650 cm-1 (C = O, s); 1539 cm-1 (N-H, s); 1186 cm-1 (SO3-, s); 1043 cm-1 (SO3-, s); 624 cm-1 (C-CO-C, s) cm-1 (C-S, w).

    (TIF)

    S2 Fig. IR-spectrum of poly(AE-SO3) with MBAA as a crosslinker.

    3418 cm-1 (OH, w, moisture); 2936 cm-1 (C-H, d); 1720 cm-1 (C = O, s); 1158 cm-1 (SO3-, s); 1036 cm-1 (SO3-, s); 607 cm-1 (C-CO-C, s); 523 cm-1 (C-S, w).

    (TIF)

    S3 Fig. IR-spectrum of poly(AE-TMA) with MBAA as a crosslinker.

    3360 cm-1 (OH, w, moisture); 2954 cm-1 (C-H, d); 1724 cm-1 (C = O, s); 1479 cm-1 (CH2, s); 1158 cm-1 (C-O, s); 952 cm-1 (C-CO-C, s).

    (TIF)

    S4 Fig. IR-spectrum of poly(HPMAA) with MBAA as a crosslinker.

    3327 cm-1 (OH, w); 2971 cm-1 (C-H, d);1634 cm-1 (C = O, s); 1522 cm-1 (N-H, s).

    (TIF)

    S5 Fig. IR-spectrum of poly(MAEDMA-SO3) with MBAA as a crosslinker.

    3420 cm-1 (OH, moisture); 2961 cm- (C-H, d); 1720 cm-1 (C = O, s); 1648 cm-1 (C = O, s); 1478 cm-1 (N-H, s); 1153 cm-1 (SO3-, s); 1030 cm-1 (SO3-, s); cm-1 (C-CO-C, s); 521 cm-1 (C-S, w).

    (TIF)

    S6 Fig. IR-spectrum of poly(MAE-SO3) with MBAA as a crosslinker.

    3441 cm-1 (OH, w, moisture); 2944 cm-1 (C-H, d); 1716 cm-1 (C = O, s); 1156 cm-1 (SO3-, s); 1038 cm-1 (SO3-, s); 609 cm-1 (C-CO-C, s); 523 cm-1 (C-S, w).

    (TIF)

    S7 Fig. IR-spectrum of poly(MAE-TMA) with MBAA as a crosslinker.

    3358 cm-1 (OH, w, moisture); 3022 cm-1 (C-H, d); 1718 cm-1 (C = O, s); 1636 cm-1 (C = O, s);1475 cm-1 (CH2, s); 1147 cm-1 (C-O, s); 949 cm-1 (C-CO-C, s).

    (TIF)

    S8 Fig. IR-spectrum of poly(VEtImBr) with MBAA as a crosslinker.

    3439 cm-1 (OH, w, moisture); 2944 cm-1 (C-H, d); 1714 cm-1 (C = O, s); 1473 cm-1 (N-H, s);1453 cm-1 (CH2, s); 1156 cm-1 (C-C-N, s); 737 cm-1 (C-CO-C, s).

    (TIF)

    S9 Fig. IR-spectrum of poly(TMA-VB) with MBAA as a crosslinker.

    3232 cm-1 (OH, w, moisture); 2963 cm-1 (= C-H, m); 1642 cm-1 (-C = C, s); 1477 cm-1 (-C = C, s); 1261 cm-1 (CH3, s); 1092 cm-1 (C -N, s); 890 cm-1 (= C-H, s).

    (TIF)

    S10 Fig. IR-spectrum of poly(MPC) with MBAA as a crosslinker.

    3340 cm-1 (OH, w, moisture); 1716 cm-1 (C-O, d); 1479 cm-1 (CH3, s); 1228 cm-1 (C-C-N, s); 1057 cm-1 (P-O, s); 954 cm-1 (C-N, s); 921 cm-1 (P-O, s); 783 cm- (C-CO-C, s).

    (TIF)

    S11 Fig. IR-spectrum of poly(HEMA) with MBAA as a crosslinker.

    3336 cm-1 (OH, w); 2961 cm-1 (C-H, d); 1706 cm-1 (C = O, s); 1632 cm-1 (C = O, s); 1448 cm-1 (CH2, s); 1261 cm-1 (C-O-C, s); 1158 cm-1 (CH3, s); 1073 cm-1 (); 892 cm-1 (C-CO-C, s).

    (TIF)

    S12 Fig. IR-spectrum of poly(MAE-TMA) with 700 PEGDA as a crosslinker.

    3362 cm-1 (OH, w, moisture);2963 cm-1 (C-H, d); 1720 cm-1 (C = O, s); 1634 cm-1 (C = O, s);1475 cm-1 (CH2, s); 1230 cm-1 (C-O, s); 947 cm-1 (C-CO-C, s).

    (TIF)

    S13 Fig. Compression curve of poly(VEtImBr) with MBAA as a crosslinker [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%].

    (TIF)

    S14 Fig. Compression curve of poly(MAEDMA-SO3) with MBAA as a crosslinker [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%].

    (TIF)

    S15 Fig. Compression curve of poly(MPC) with MBAA as a crosslinker [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%].

    (TIF)

    S16 Fig. Compression curve of poly(AAMPSO3H) with MBAA as a crosslinker [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%].

    (TIF)

    S17 Fig. Compression curve of poly(HPMAA) with MBAA as a crosslinker [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%].

    (TIF)

    S18 Fig. Compression curve of poly(HEMA) with MBAA as a crosslinker [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%].

    (TIF)

    S19 Fig. Compression curve of poly(VEtImBr) with MBAA as a crosslinker [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%].

    (TIF)

    S20 Fig. Compression curve of poly(MPC) with MBAA as a crosslinker [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%].

    (TIF)

    S21 Fig. Compression curve of poly(AAMPSO3H) with MBAA as a crosslinker [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%].

    (TIF)

    S22 Fig. Compression curve of poly(HPMAA) with MBAA as a crosslinker [22 ± 2 °C; n ≥ 3; M: 2 mol/L; MBAA: 2 mol%].

    (TIF)

    S23 Fig

    (TIF)

    S1 Data

    (PDF)

    Attachment

    Submitted filename: Response to Reviewer.pdf

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES